Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4
|
|
- Julie Ryan
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p Vol. 41, No /03/$ DOI: /JCM The World Health Organization s External Quality Assurance System Proficiency Testing Program Has Improved the Accuracy of Antimicrobial Susceptibility Testing and Reporting among Participating Laboratories Using NCCLS Methods Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4 Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1 and World Health Organization Collaborating Center for Global Antimicrobial Resistance Monitoring, 2 Atlanta, Georgia 30333; World Health Organization, Geneva, Switzerland 3 ; and World Health Organization Collaborating Center for Surveillance of Antimicrobial Resistance, Brigham and Women s Hospital, Boston, Massachusetts Received 19 December 2002/Returned for modification 27 January 2003/Accepted 25 March 2003 A total of 150 laboratories in 33 countries that followed the NCCLS testing procedures participated in the World Health Organization s External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST) from January 1998 through March Laboratories tested seven bacterial isolates for antimicrobial resistance and reported the results to the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga. The results were compared to the results generated at the CDC with the NCCLS broth microdilution and disk diffusion reference methods. Although there were few testing errors with Salmonella enterica subsp. enterica serovar Enteritidis, drugs that are not appropriate for therapy of Salmonella infections were tested and reported by 136 (91%) of 150 laboratories. In addition, 29 (20%) of 150 laboratories used the Staphylococcus aureus breakpoints to report oxacillin results for Staphylococcus saprophyticus. For a vanbcontaining Enterococcus faecalis strain, 124 (83%) of 150 laboratories correctly reported vancomycin results that were 1 doubling dilution from the reference MIC or 3 mm from the reference disk diffusion result. Of the laboratories that tested Streptococcus agalactiae by disk diffusion, 17% reported nonsusceptible results for penicillin in error. While 110 laboratories (73%) tested the S. pneumoniae challenge isolate against a fluoroquinolone, 83% tested it against ciprofloxacin, for which there are no NCCLS interpretive criteria. Ten of 12 laboratories testing levofloxacin and 4 of 4 laboratories testing ofloxacin by an MIC method correctly reported resistant results for the isolate. Feedback letters sent to participating laboratories highlighted areas of susceptibility testing in individual laboratories that needed improvement. The positive impact of the feedback letters and the overall effectiveness of the EQAS program were documented in repeat testing challenges with pneumococci and staphylococci. The 31 and 19% increases in the numbers of laboratories using appropriate testing methods for pneumococci and staphylococci, respectively, in 2000 versus 1998 indicate that laboratory performance is improving. Clinical microbiology laboratories, through routine antimicrobial susceptibility testing and participation in various surveillance programs, help monitor the development and spread of antimicrobial resistance in their communities. The accuracy of data generated by both formal and informal surveillance systems has been debated for several years, which has led to a call for more careful monitoring of laboratory performance through external quality assurance and proficiency testing programs (12, 15). Proficiency testing is an external quality assurance method in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine laboratory methods. Proficiency testing provides data about the accuracy of susceptibility testing and can determine if a laboratory s * Corresponding author. Mailing address: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS G-08, Atlanta, GA Phone: (404) Fax: (404) zoa6@cdc.gov. The members of the WHO Antimicrobial Resistance Group are Rosamund Williams, Philip Jenkins, John Stelling, and Thomas O Brien. methods are sufficiently sensitive to detect novel resistance patterns. This method of quality assurance also allows a clinical laboratory s performance to be assessed in comparison to reference methods and to other peer laboratories. Several reports suggest that providing feedback on proficiency testing results improves the quality of testing among clinical laboratories (7, 8, 17). A previous report on the External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST), coordinated by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), highlighted the types of testing errors that were common among participating laboratories (15). The goals of the present study were (i) to determine if laboratories are following the NCCLS guidelines for reporting results for salmonellae and coagulase-negative staphylococci (CoNS); (ii) to assess the accuracy with which laboratories test and report results for group B streptococci, vanb-containing enterococci, and fluoroquinolone-resistant pneumococci; and (iii) to determine if feedback letters with specific recommendations for modifying susceptibility 2372
2 VOL. 41, 2003 ANTIMICROBIAL SUSCEPTIBILITY PROFICIENCY TESTING 2373 TABLE 1. Antimicrobial agents tested and reported for S. enterica subsp. enterica serovar Enteritidis a Antimicrobial agent(s) testing strategies improve the performance of laboratories when they are rechallenged with similar organisms. MATERIALS AND METHODS No. of laboratories reporting results for each antimicrobial agent (%) Recommended Ampicillin (94) Chloramphenicol (78) Fluoroquinolones (87) Trimethoprim-sulfamethoxazole (91) Expanded-spectram cephalosporins (91) Inappropriate Aminoglycosides (80) Aztreonam (65) Imipenem (79) Piperacillin (75) Narrow- and improved-spectram cephalosporins (42) a Not all of the laboratories tested all of the antimicrobial agents listed. Distribution. The following organisms were sent to approximately 300 laboratories outside of the United States: vancomycin-intermediate Staphylococcus epidermidis and penicillin-susceptible Streptococcus pneumoniae in 1998, vanbcontaining Enterococcus faecalis and fluoroquinolone-resistant S. pneumoniae in 1999, ampicillin- and tetracycline-resistant Salmonella enterica subsp. enterica serovar Enteritidis and penicillin-susceptible S. pneumoniae in 2000 (the same isolate that was sent in 1998), Staphylococcus saprophyticus (a CoNS), a group B beta-hemolytic streptococcus, and vancomycin-intermediate S. epidermidis in 2001 (the same isolate that was sent in 1998). Coordinating centers were established in Argentina, Bulgaria, China, Colombia, Croatia, the Czech Republic, Finland, Korea, Japan, and Saudi Arabia to facilitate the distribution of organisms and reporting of results. Testing. Participants were instructed to test the organisms only once with their standard testing method. Laboratories were directed to process the isolate as if it had been obtained from a positive blood culture. For each organism, a data collection sheet was provided that solicited information on the antimicrobial susceptibility testing method used (MIC or disk diffusion), sources of media and reagents, interpretive criteria used (e.g., NCCLS [9 11], the Comité de l Antibiogramme de la Société de Française Microbiologie [5], or the British Society for Antimicrobial Chemotherapy [18, 19]), and disk potency. The data sheets included a suggested set of antimicrobial agents to test and provided space to fill in additional drugs that were tested in the laboratory. Laboratories were asked to provide both quantitative results (MICs or zone diameters) and the qualitative interpretations (i.e., susceptible, intermediate, or resistant) for each antimicrobial agent tested. Some laboratories reported using WHONET software as the source of their interpretative criteria (14). The organisms were tested TABLE 3. Interpretative errors for testing of S. saprophyticus Test result 3 reference result a (error type) multiple times at the CDC by broth microdilution (BMD) and disk diffusion by NCCLS methods (9 11) to establish the reference MIC and disk diffusion values. The MIC testing methods reported by participating laboratories included Etest, Microscan, Vitek, and Sensititre; however, the methods and media used were not consistently reported. Data analysis. Data sheets were returned by the individual laboratories or the coordinating centers to the CDC within 2 months of receipt of the proficiency test organisms. The data were entered into an SAS data set (SAS, Cary, N.C.). The data set for this report includes results from 150 laboratories representing 33 countries that use NCCLS methods. Calculated mean values were rounded to the nearest whole number. Feedback and follow-up. Feedback letters describing the resistance patterns of the challenge organisms and summarizing the results from individual laboratories in comparison to all other laboratories were sent to the individual laboratories or to the coordinating centers for distribution to their participants. In addition, we conducted an anonymous survey of participants to determine the usefulness of the EQAS-AST proficiency testing program. RESULTS No. of laboratories Erythromycin Oxacillin Penicillin S 3 R (very major) R 3 S (major) S 3 I (minor) I 3 S (minor) R 3 I (minor) I 3 R (minor) Total a S, susceptible; I, intermediate. R, resistant. Reporting of challenges. One hundred fifty participants reported results for an S. enterica subsp. enterica serovar Enteritidis isolate that was resistant to ampicillin and tetracycline but susceptible to chloramphenicol, ciprofloxacin, and trimethoprim-sulfamethoxazole. Of the 150 laboratories, 26% used an MIC method and 74% used disk diffusion. Only one laboratory reported a susceptible result for ampicillin, and another reported a susceptible result for tetracycline. However, 136 laboratories (91%) tested and reported agents other than those recommended by the NCCLS for Salmonella infections, such as gentamicin, narrow- and improved-spectrum cephalosporins, and imipenem (Table 1). No laboratories reported false resistance to fluoroquinolones. Of 150 laboratories, 139 (93%) were able to identify the staphylococcal challenge organism as a CoNS, 3 (2%) identi- Antimicrobial agent BMD ( g/ml) Reference result (category) c DD a (mm) TABLE 2. Results for S. saprophyticus No. of laboratories reporting results Correct results Interpreted correctly b BMD DD BMD DD Erythromycin 0.5 (S) 25 (S) (78) d 47 (47) 32 (100) 45 (96) Penicillin 0.5 (R) 22 (R) (46) 56 (57) 16 (100) 55 (98) Oxacillin 1.0 (R) 12 (R) (82) 66 (65) 19 (61) 49 (74) b Interpretation based on NCCLS criteria (11). c S, susceptible; R, resistant. d The values in parentheses are percentages of the total.
3 2374 CHAITRAM ET AL. J. CLIN. MICROBIOL. Antimicrobial agent (no. of laboratories) BMD ( g/ml) Reference result (category) c TABLE 4. Results for E. faecalis No. of laboratories reporting DD results (range in mm) c No. of laboratories reporting MIC results (range in g/ml) c DD (mm) a S I R S I R Ampicillin (146) 1 (S) 23 (S) 97 (19 33) 0 5 (6 15) 44 (0.19 8) 0 0 Penicillin (131) 4 (S) 17 (S) 85 (15 34) 0 8 (6 14) 38 ( ) 0 0 Teicoplanin (84) 0.5 (S) b 18 (S) b 52 (14 24) 3 (12 13) 0 29 ( ) 0 0 Vancomycin (149) 32 (R) 15 (I) 13 (17 23) 22 (15 16) 48 (6 14) 13 ( 0.5 4) 15 (8 16) 38 (32 256) b Consistent with a VanB phenotype. c S, susceptible; I, intermediate; R, resistant. fied the organism as S. aureus, and 8 (5%) did not report an identification. Of the 139 that identified the organism as a CoNS, 122 (88%) correctly identified the organism as S. saprophyticus. Of 140 laboratories that tested and reported results for oxacillin, 97 (70%) obtained the correct MIC within 1 doubling dilution of the reference MIC or the correct diameter within 3 mm of the reference disk diffusion result. Of those that obtained the correct results, 61% of the MICs and 74% of the disk diffusion results, respectively, were interpreted with the appropriate interpretative criteria for oxacillin (Table 2), i.e., those for CoNS. Nineteen laboratories (20%) reported this organism as oxacillin susceptible, resulting in 19 very major errors (11 obtained by the BMD or Etest method and 8 obtained by disk diffusion). In addition, 10 laboratories (10%) reported this organism as intermediate to oxacillin, resulting in 10 minor errors (1 obtained by an MIC method and 9 obtained by disk diffusion) (Table 3). Testing challenges. Laboratories were sent a vanb-containing E. faecalis isolate that was vancomycin resistant but penicillin and ampicillin susceptible. Five (3%) laboratories reported the organism as ampicillin resistant, and eight (6%) reported the organism as penicillin resistant; in addition, one laboratory reported a beta-lactamase-positive result, which was incorrect (Table 4). Seventy-four (89%) out of 83 laboratories correctly reported disk diffusion results within 3 mmofthe reference result. Forty-seven (71%) of 66 laboratories testing by an MIC method reported a result that was 1 doubling dilution of the CDC result. Of the 13 laboratories that reported vancomycin-susceptible results for the disk diffusion method, only two reported an unacceptably large zone diameter. The results for the S. pneumoniae challenge are shown in Table 5. This strain is susceptible to penicillin and cephalosporins but resistant to fluoroquinolones. Ninety-one of the 110 laboratories that tested a fluoroquinolone chose ciprofloxacin, for which there are no NCCLS interpretive criteria. The zone diameter results for ciprofloxacin ranged from no zone to 35 mm; with a mean of 15 mm. Ten of 12 laboratories that tested levofloxacin and all 4 of the laboratories testing ofloxacin reported resistant results consistent with the NCCLS interpretive criteria. The group B beta-hemolytic streptococcus (S. agalactiae) challenge strain was resistant to erythromycin and tetracycline but remained susceptible to penicillin, extended-spectrum cephalosporins, and clindamycin. It contains the mef(a) macrolide efflux gene, which mediates resistance to erythromycin but not clindamycin. Sixty percent of disk diffusion users reported this strain as erythromycin intermediate rather than resistant, which is consistent with the relatively low erythromycin MIC of 8 g/ml. The organism should be reported as clindamycin susceptible, although 10 laboratories, all disk diffusion users, reported intermediate or resistant results. Seven laboratories (7%) using disk diffusion reported this strain as penicillin resistant although the reference zone diameter result for penicillin was very large (30 mm). A total of 11 laboratories reported resistant disk diffusion results for cefotaxime and or ceftriaxone (Table 6). Repeat challenges to assess improvement in test selection. A pneumococcal isolate with reduced susceptibility to penicillin was sent in 1998 and again in 2000 and was tested both times by a subset of 52 laboratories. This organism produces a zone size of 13 to 15 mm around a 1- g oxacillin disk, indicating that a penicillin MIC test should be performed. In 1998, 32 (71%) out of 45 laboratories testing oxacillin reported a zone of 19 mm, while in 2000, 22 (69%) out of 32 testing oxacillin reported a zone diameter of 19 mm. Although the MIC of penicillin for this organism is typically in the susceptible range (modal MIC 0.06 g/ml), penicillin MICs as high as 0.5 g/ml, interpreted as intermediate, were reported by two laboratories in 2000 (Table 7). MIC results of g/ml were Antimicrobial agent (no. of laboratories) BMD ( g/ ml) TABLE 5. Results for S. pneumoniae No. of laboratories reporting DD results (range in mm) b No. of laboratories reporting MIC results (range in g/ml) b DD (mm) a S I R S I R Levofloxacin (12) 8 (R) 10 (R) 0 1 (14) 8 (6 12) 1 ( 0.5) 0 2 (8 16) Penicillin (107) 0.01 (S) 0 54 (52 45) 0 1 (12) 50 ( ) 1 (0.5) 1 (4)
4 VOL. 41, 2003 ANTIMICROBIAL SUSCEPTIBILITY PROFICIENCY TESTING 2375 TABLE 6. Results for S. agalactiae Antimicrobial agent (no. of laboratories) No. of laboratories reporting DD results (range in mm) b No. of laboratories reporting MIC results (range in g/ml) b BMD ( g/ml) DD (mm) a S I R S I R Cefotaxime (100) 0.03 (S) 30 (S) 74 (24 40) 0 5 (6 23) 21 ( ) 0 0 Ceftriaxone (86) 0.06 (S) 28 (S) 65 (25 40) 0 10 (8 22) 11 ( ) 0 0 Clindamycin (138) 0.25 (S) 21 (S) 89 (19 31) 8 (16 18) 2 (6 15) 39 ( ) 0 0 Erythromycin (142) 8 (R) 14 (R) 4 (21 25) 61 (16 20) 36 (6 15) 7 ( 0.25) 1 (0.5) 33 (1 8) Penicillin (145) 0.06 (S) 30 (S) 89 (24 38) 0 7 (6 21) 49 ( ) 0 0 considered errors. Eight laboratories used penicillin disks in 2000, compared to 10 laboratories in 1998, with only 2 laboratories making the same error twice. In 1998, 18 laboratories tested cefotaxime and/or ceftriaxone by disk diffusion although there are no interpretive criteria for penicillin and cephalosporin disks in the NCCLS guidelines for this organism. In 2000, the number dropped to 13 laboratories. In 1998, 18 (35%) of 52 laboratories reported oxacillin screen test results of 19 mm without follow-up MIC testing whereas that number dropped to 7 (13%) of 52 in Thus, 16 (31%) of 52 laboratories improved their testing methods for penicillin, cephalosporins, or both drug classes in Finally, this isolate is also erythromycin resistant. In 2000, no laboratories reported erythromycin-susceptible results, which is an improvement over 1998, when 10% of the laboratories reported the isolate as erythromycin susceptible. A glycopeptide-intermediate strain of S. epidermidis, previously sent in 1998, was sent to participants again in The vancomycin MIC for this organism was 8 g/ml, and the teicoplanin MIC was 16 g/ml (Table 8). Of the 52 laboratories that tested this organism in both 1998 and 2001, 12 changed their testing method for this isolate for vancomycin from disk diffusion to an MIC method in 2001, resulting in a 19% improvement in the results. Follow-up survey. Of 115 laboratories returning the survey, 107 (93%) received feedback letters from the CDC or their coordinating centers critiquing their results. Ninety-nine of those (93%) shared this information with laboratory staff. Thirty-four percent made changes to their method of testing on the basis of the CDC s, or their coordinating center s, recommendations. Six of seven responding coordinating centers will continue to distribute proficiency test strains and feedback of results to laboratories after the EQAS-AST program is completed. DISCUSSION In the past, proficiency testing programs for antimicrobial susceptibility testing have focused primarily on testing accuracy. However, equally important is assessment of reporting accuracy. Although there were few testing errors with the S. enterica subsp. enterica serovar Enteritidis and S. saprophyticus isolates, there were multiple reporting errors with these organisms. NCCLS guidelines state that certain antimicrobial agents should not be tested or reported for Salmonella species because they may give false-susceptible results. Nonetheless, 136 laboratories tested and reported antimicrobial agents that are inappropriate for Salmonella infections (Table 1). Although salmonellae are tested with the same set of disks or MIC panels used for other gram-negative enteric organisms, laboratories must ensure that only the appropriate antimicrobial agents are reported. Some antimicrobial agents, such as the aminoglycosides, are always inappropriate; on the other hand, extended-spectrum cephalosporins, such as cefotaxime and ceftriaxone, are appropriate to report for extraintestinal Salmonella infections. Thus, it is important to test and report these agents selectively. In 2000, NCCLS changed the oxacillin breakpoints for CoNS to 0.25 g/ml or 18 mm for susceptible and 0.5 g/ml and 17 mm for resistant (no intermediate disk breakpoint). These breakpoints correlate much better with the results of meca testing for most CoNS strains. The purpose of the S. saprophyticus challenge was to verify that laboratories are aware of this change. Since the S. saprophyticus challenge organism demonstrates an oxacillin MIC of 1 g/ml and a zone diameter much smaller than the breakpoint of 17 mm (the mean was 12 mm), it would be classified as resistant by the new NCCLS criteria, presuming that the organism was not isolated from urine. In most instances, S. saprophyticus is recovered from the urinary TABLE 7. Results for S. pneumoniae TABLE 8. Results for S. epidermidis Antimicrobial agent No. of laboratories reporting results b in: BMD ( g/ml) DD (mm) a S I R S I R Antimicrobial agent No. of laboratories reporting results b in: BMD ( g/ml) DD (mm) a S I R S I R Clindamycin 0.12 (S) 22 (S) Erythromycin 4 (R) 10 (R) Penicillin 0.06 (S) Oxacillin 16 (R) 6 (R) Teicoplanin 16 (I) 14 (S) Vancomycin 8 (I) 16 (S)
5 2376 CHAITRAM ET AL. J. CLIN. MICROBIOL. tract and, according to the NCCLS, does not require routine testing because these infections respond to antimicrobial agents commonly used to treat acute, uncomplicated urinary tract infections (e.g., nitrofurantoin, trimethoprim-sulfamethoxazole, or a fluoroquinolone) (11). Because 29 laboratories reported this organism as susceptible or intermediate to oxacillin, resulting in 19 very major errors and 10 minor errors, respectively, it is clear that many laboratories used the S. aureus breakpoints even when 88% of the laboratories correctly identified this organism as S. saprophyticus. The E. faecalis challenge strain was V583, the first vanbcontaining (low-level vancomycin resistance) strain reported from the United States. This strain typically yields vancomycin MIC and disk diffusion results in the intermediate range (13). Although the mean vancomycin MIC reported by participating laboratories was 64 g/ml (resistant), the disk diffusion mean was 14 mm (resistant). The NCCLS recommends incubating both MIC and disk diffusion tests for a full 24 h before reading and interpreting results and also recommends retesting of isolates that yield disk diffusion results in the intermediate range by an MIC method (9 11). The vancomycin zones for enterococci should be read with transmitted light instead of reflected light, and any isolates with haze or growth within the zone of inhibition should be considered resistant. Disk diffusion results for vancomycin for enterococci are usually more difficult to interpret than MIC results. It is possible that the teicoplaninsusceptible results typical of vanb-containing strains caused some laboratories to assume that borderline vancomycin-resistant results were in error. In retrospect, this organism would not have been a good choice for proficiency testing if only qualitative results were considered because the accuracy of the disk diffusion tests spans the interpretative categories of susceptible, intermediate, and resistant. However, when the accuracy of the results is assessed independently of the interpretation, only 10% of laboratories reported vancomycin MICs more than 1 doubling dilution from the reference value or disk diffusion results greater than 3 mm from the reference disk result. These data are encouraging since previous studies have documented the difficulties in detecting low-level vancomycin resistance (1, 4, 16). S. agalactiae is an unusual proficiency-testing organism, but given the increased emphasis on detecting this organism in pregnant women (2) and the concern over increasing macrolide resistance in group B streptococci, we decided to include it as one of our challenges. While the NCCLS has published disk diffusion breakpoints for beta-lactam drugs such as penicillin, cefotaxime, and ceftriaxone, these tests can be difficult to read. Seven laboratories reported false penicillin resistance obtained by disk diffusion, and one laboratory reported falseresistance obtained by an MIC method. To our surprise, 11 laboratories reported resistance to cefotaxime and/or ceftriaxone. Penicillin and cephalosporin resistance has not been reported in group B streptococci. Fluoroquinolone resistance is emerging in pneumococci in several countries (3, 6). Although there are no NCCLS breakpoints for ciprofloxacin for S. pneumoniae, 91 (61%) laboratories tested this antimicrobial agent and 79 (87%) of these laboratories reported an interpretation for ciprofloxacin for our pneumococcal challenge organism in The mean disk diffusion result was 15 mm, which was reported by 15 laboratories, and 13 (87%) of these laboratories interpreted this result as indicating resistance. Nine laboratories tested ciprofloxacin by an MIC method, and six of these laboratories reported interpretations, all indicating resistance. Twelve laboratories (8%) tested the S. pneumoniae challenge against levofloxacin; four tested ofloxacin and one tested trovafloxacin. Breakpoints have been established for the latter three antimicrobial agents. In 1998, participants were sent a pneumococcal isolate that was resistant to erythromycin but susceptible to chloramphenicol and beta-lactam drugs such as penicillin and cefotaxime. In addition, this pneumococcal isolate consistently gives an oxacillin zone diameter of 19 mm and so, according to NCCLS guidelines, the laboratory should perform an MIC test rather than report a result based on the oxacillin screen test alone. Participants were also challenged with an S. epidermidis isolate with reduced susceptibility to vancomycin. As noted previously, disk diffusion does not detect decreased susceptibility to glycopeptides in staphylococci (16); however, many laboratories continue to use disk diffusion to test staphylococci against glycopeptides. Although disk diffusion works well for most other drug classes, alternate testing methods for glycopeptides must be used. For laboratories that routinely use disk diffusion, the BHI vancomycin agar screen test, which was developed for enterococci, can be used to detect strains of staphylococci with reduced susceptibility to vancomycin and teicoplanin. Feedback letters were sent to participants in 1998 including recommendations to improve testing methods for the pneumococci and staphylococci. The same laboratories were challenged again with the pneumococcal and staphylococcal isolates 2 years later to assess whether laboratory performance had improved. In 1998, only 27 (52%) out of 52 laboratories tested the S. pneumoniae isolate correctly with an MIC method for penicillin, although 32 (71%) out of 45 reported an oxacillin zone diameter of 19 mm. This improved to 73% in 2000 with 38 out of 52 laboratories performing an MIC test for penicillin although only 22 (68%) out of 32 reported a zone diameter of 19 mm for oxacillin. There were more laboratories correctly using an MIC method for penicillin in 2000, although the number of laboratories accurately testing oxacillin did not significantly change. Moreover, only 10% of the laboratories in 1998 were able to detect reduced susceptibility to vancomycin in staphylococci; this improved to 29% in Only two laboratories reported using the BHI vancomycin agar screen test in 1998 and 2000, and these laboratories were not the same in each year. Although many laboratories continue to use incorrect testing methods (e.g., disk diffusion for testing of pneumococci with penicillin and for detection of reduced susceptibility to vancomycin in staphylococci), our results indicate that laboratory performance can be improved by proficiency tests, followed by feedback of results. In some cases, laboratories were aware of the correct testing methods (and noted this on their data collection sheets) but, because of financial limitations, were not able to use the appropriate test methods. The improved performance of the laboratories and positive survey responses support the belief that the EQAS-AST program has been very useful in identifying areas for improvement in susceptibility testing methods and, in some cases, has led to better laboratory performance.
6 VOL. 41, 2003 ANTIMICROBIAL SUSCEPTIBILITY PROFICIENCY TESTING 2377 ACKNOWLEDGMENTS We thank all WHO EQAS-AST participants for sending their results. We also thank the EQAS-AST coordinating centers, the WHO regional offices, and the CDC shipping department for distributing proficiency test organisms. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. REFERENCES 1. Alonso-Echanove, J., B. Robles, W. R. Jarvis, and The Spanish VRE Study Group Proficiency of clinical laboratories in Spain in detecting vancomycin-resistant Enterococcus spp. J. Clin. Microbiol. 37: Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease, revised guidelines from CDC. Morb. Mortal. Wkly. Rep. 51: Chen, D. K., A. McGreer, J. C. de Azavedo, and D. E. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341: Cookson, S. T., H. Lopardo, M. Marin, R. Arduino, M. J. Rial, M. Altschuler, L. Galanternik, J. M. Swenson, F. C. Tenover, J. I. Tokars, and W. R. Jarvis An Argentine-United States study to determine the ability of clinical laboratories to detect antimicrobial-resistant enterococcus isolates. Diagn. Microbiol. Infect. Dis. 29: Goldstein, F., C. J. Soussy, and A. Thabaut Report of the Comité de l Antibiogramme de la Société Française de Microbiologie. Definition of the clinical antibacterial spectrum of activity. Clin. Microbiol. Infect. 2:S40 S Ho, P. L., R. W. H. Yung, D. N. C. Tsang, T. L. Que, M. Ho, W. H. Seto, T. K. Ng, W. C. Yam, and W. S. Wilson Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in J. Antimicrob Chemother. 48: Juniper, I. R Quality issues in proficiency testing. Accred. Qual. Assur. 4: King, A., and D. F. J. Brown Quality assurance of antimicrobial susceptibility testing by disk diffusion. J. Antimicrob. Chemother. 48(Suppl. S1): NCCLS Performance standards for antimicrobial disk susceptibility tests, 7th edition, vol. 20, no. 1. Approved standard M2-A7. NCCLS, Wayne, Pa. 10. NCCLS Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th edition, vol. 17, no. 2. Approved standard M7-A5. NCCLS, Wayne, Pa. 11. NCCLS Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement M100-S10. NCCLS, Wayne, Pa. 12. Richet, H. M., J. M. Mohammed, L. C. McDonald, and W. R. Jarvis Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg. Infect. Dis. 7: Sahm, D. F., J. Kissinger, M. S. Gilmore, P. R. Murray, R. Mulder, J. Solliday, and B. Clarke In vitro susceptibility studies of vancomycinresistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33: Stelling, J. M., and T. F. O Brien Surveillance of antimicrobial resistance: the WHONET program. Clin. Infect. Dis. 24(Suppl. S1): Tenover, F. C., M. J. Mohammed, J. Stelling, T. O Brien, and R. Williams Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization s External Quality Assurance System for antimicrobial testing. J. Clin. Microbiol. 39: Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O Hara, S. A. McAllister, N. C. Clark, and K. Hiramatsu Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36: Wood, R., and M. Thompson Proficiency testing in analytical laboratories: how to make it work. Accred. Qual. Assur. 1: Working Party of the British Society for Antimicrobial Chemotherapy Breakpoints in-vitro antibiotic susceptibility testing. J. Antimicrob. Chemother. 21: Working Party of the British Society for Antimicrobial Chemotherapy Supplementary report on antibiotic sensitivity testing. J. Antimicrob. Chemother. 38: Downloaded from on October 12, 2018 by guest
a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationAnnual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More information/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2001, p. 241 250 Vol. 39, No. 1 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.1.241 250.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Ability
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationUse of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3341 3348 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Use of the National Committee for
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationSUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.
SUPPLEMENT ARTICLE Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe,
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationService Delivery and Safety Department World Health Organization, Headquarters
Service Delivery and Safety Department World Health Organization, Headquarters WHO global (laboratory-based) survey on multidrug-resistant organisms (MDROs) in health care PROJECT SUMMARY Given the important
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationShort Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing
Short Report Frequent major errors in antimicrobial susceptibility testing of bacterial strains distributed under the Deutsches Krebsforschungszentrum Quality Assurance Program R Boot Former Section of
More informationENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN
ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST
More informationCAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods
CAP Laboratory Improvement Programs Performance Accuracy of Antibacterial and Antifungal usceptibility Test Methods Report From the College of American Pathologists Microbiology urveys Program (001 003)
More informationIn vitro activity of telavancin against recent Gram-positive clinical isolates: results of the Prospective European Surveillance Initiative
Journal of Antimicrobial Chemotherapy (2008) 62, 116 121 doi:10.1093/jac/dkn124 Advance Access publication 19 April 2008 In vitro activity of telavancin against recent Gram-positive clinical isolates:
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationAgent-Resistant Enterococci
JOURNAL OF CLINICAL MICROBIOLOGY, July 1993, p. 1695-1699 0095-1137/93/071695-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 31, No. 7 Ability of Clinical Laboratories To Detect Antimicrobial
More informationSTAPHYLOCOCCI: KEY AST CHALLENGES
Romney Humphries, PhD D(ABMM) Section Chief, UCLA Clinical Microbiology Los Angeles CA rhumphries@mednet.ucla.edu STAPHYLOCOCCI: KEY AST CHALLENGES THE CHALLENGES detection of penicillin resistance detection
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationAre Clinical Laboratories in California Accurately Reporting Vancomycin-Resistant Enterococci?
JOURNAL OF CLINICAL ROBIOLOGY, Oct. 1997, p. 2526 2530 Vol. 35, No. 10 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Are Clinical Laboratories in California Accurately Reporting
More informationAntimicrobial Resistance Trends in the Province of British Columbia
655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationMethod Preferences and Test Accuracy of Antimicrobial Susceptibility Testing
Method Preferences and Test Accuracy of Antimicrobial Susceptibility Testing Updates From the College of American Pathologists Microbiology Surveys Program (2000) Ronald N. Jones, MD; for the College of
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationAbility of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories
Diagnostic Microbiology and Infectious Disease 38 (2000) 59 67 Surveillance www.elsevier.com/locate/diagmicrobio Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens:
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI
HAEMOLYTIC STREPTOCOCCI This specimen was designated as a sample from a skin wound that was to be cultured, identified to species level and susceptibility tested [1-3]. The culture contained a Streptococcus
More informationEvaluation of the BIOGRAM Antimicrobial Susceptibility Test System
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationBactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21
www.wslhpt.org 2601 Agriculture Drive Madison, WI 53718 (800) 462-5261 (608) 265-1111 2015-BactiR Reg3 Shipment Date: September 14, 2015 Questions or comments should be directed to Amanda Weiss at 800-462-5261
More informationGroup b strep and macrodantin
Group b strep and macrodantin The Borg System is 100 % Group b strep and macrodantin 12-10-2017 Group B Streptococcus, also known as Streptococcus agalactiae, was once considered a pathogen of only domestic
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationKey words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin
Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationVolume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article
Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Copyrights@2016 Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article A STUDY ON ANTIBIOTIC SUSCEPTIBILITY
More informationDefining Resistance and Susceptibility: What S, I, and R Mean to You
Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible
More informationProtocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland
Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland Version 1.0 23 December 2011 General enquiries and contact details This is the first version (1.0) of the Protocol
More informationSurveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler
Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationMain objectives of the EURL EQAS s
EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)
More informationIn Vitro Activities of the Novel Cephalosporin LB against Multidrug-Resistant Staphylococci and Streptococci
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2004, p. 53 62 Vol. 48, No. 1 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.1.53 62.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationOver the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.
Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing
More informationSusceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System
Polish Journal of Microbiology 2005, Vol. 54, No 4, 311 316 Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System EL BIETA STEFANIUK*, AGNIESZKA MRÓWKA
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationOriginal Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.
Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationDalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01051.x Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres A. C. Gales 1, H. S. Sader 1,2
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationEpidemiology and Microbiology of Surgical Wound Infections
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 918 922 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Epidemiology and Microbiology of Surgical
More informationAntimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control
Antimicrobial Resistance Trends in the Province of British Columbia August 2008 Epidemiology Services British Columbia Centre for Disease Control 5 Table of Contents Executive Summary...5 Objective...6
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationReceived 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationAntimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil
BJID 2001; 5 (August) 171 Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil Helio S. Sader, Ana C. Gales and Ronald N. Jones Special Clinical Microbiology Laboratory, Division
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationRESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN
RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN Hussein Azzam Bataineh 1 ABSTRACT Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant
More informationTECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 www.ecdc.europa.eu ECDC TECHNICAL REPORT External quality
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationMonitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco
Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Outline EURL-AR
More informationLeveraging the Lab and Microbiology Department to Optimize Stewardship
Leveraging the Lab and Microbiology Department to Optimize Stewardship Presented by: Andrew Martinez MLS(ASCP), MT(AMT), MBA Alaska Native Medical Center Microbiology Supervisor Maniilaq Health Center
More informationClinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET
Special Articles Journal of General and Family Medicine 2015, vol. 16, no. 3, p. 138 142. Clinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET Sachiko Satake, PhD,
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationSAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More information